These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15642451)

  • 1. Topiramate related obsessive-compulsive disorder.
    Ozkara C; Ozmen M; Erdogan A; Yalug I
    Eur Psychiatry; 2005 Jan; 20(1):78-9. PubMed ID: 15642451
    [No Abstract]   [Full Text] [Related]  

  • 2. Topiramate-induced psychosis.
    Kober D; Gabbard GO
    Am J Psychiatry; 2005 Aug; 162(8):1542. PubMed ID: 16055782
    [No Abstract]   [Full Text] [Related]  

  • 3. Topiramate augmentation in a patient with obsessive-compulsive disorder.
    Van Ameringen M; Patterson B
    J Psychiatry Neurosci; 2015 Sep; 40(5):E31-2. PubMed ID: 26290064
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder.
    Rubio G; Jiménez-Arriero MA; Martínez-Gras I; Manzanares J; Palomo T
    J Clin Psychopharmacol; 2006 Jun; 26(3):341-4. PubMed ID: 16702907
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of new and established antiepileptic drugs.
    Leppik IE
    Epilepsia; 1998; 39 Suppl 5():2-6. PubMed ID: 9737436
    [No Abstract]   [Full Text] [Related]  

  • 6. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.
    Hollander E; Dell'Osso B
    Int Clin Psychopharmacol; 2006 May; 21(3):189-91. PubMed ID: 16528143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Wada and neuropsychological testing results due to topiramate therapy.
    McCabe PH; Eslinger PJ
    Epilepsia; 2000 Jul; 41(7):906-8. PubMed ID: 10897166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Topiramate augmentation in treatment-resistant obsessive-compulsive disorder].
    Vinkers DJ; van der Wee NJ
    Tijdschr Psychiatr; 2008; 50(11):747-50. PubMed ID: 18991236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin.
    Zullino DF; Krenz S; Zimmerman G; Miozzari A; Rajeswaran R; Kolly S; Khazaal Y
    Subst Abus; 2004 Dec; 25(4):27-33. PubMed ID: 16172090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate may induce obsessive-compulsive disorder.
    Thuile J; Even C; Guelfi JD
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):394. PubMed ID: 16732760
    [No Abstract]   [Full Text] [Related]  

  • 11. Topiramate--add-on drug for partial seizures.
    Drug Ther Bull; 1996 Aug; 34(8):62-4. PubMed ID: 8810129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar Rates of Autism With Lamotrigine, Topiramate, and No Treatment; Rate With Valproate Is Higher.
    Speer L
    Am Fam Physician; 2024 Jul; 110(1):90-91. PubMed ID: 39028792
    [No Abstract]   [Full Text] [Related]  

  • 13. What does the future hold for patients with epilepsy?
    Faught E
    Lancet Neurol; 2012 Apr; 11(4):298-300. PubMed ID: 22377179
    [No Abstract]   [Full Text] [Related]  

  • 14. Epilepsy in children: the evidence for new antiepileptic drugs.
    Verdru P
    Acta Neurol Scand Suppl; 2005; 181():17-20. PubMed ID: 16238703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compulsive buying treatment with topiramate, a case report.
    Guzman CS; Filomensky T; Tavares H
    Braz J Psychiatry; 2007 Dec; 29(4):383-4. PubMed ID: 18200404
    [No Abstract]   [Full Text] [Related]  

  • 16. The new antiepileptic drugs.
    Macleod S; Appleton RE
    Arch Dis Child Educ Pract Ed; 2007 Dec; 92(6):182-8. PubMed ID: 18032714
    [No Abstract]   [Full Text] [Related]  

  • 17. Monotherapy of epilepsy in women: psychiatric and neuroendocrine aspects.
    Zheleznova EV; Kalinin VV; Zemlyanaya AA; Sokolova LV; Medvedev IL
    Neurosci Behav Physiol; 2010 Feb; 40(2):157-62. PubMed ID: 20033304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antiepileptic drugs: case studies.
    Bannister SM; Morton LD; Pellock JM
    Semin Pediatr Neurol; 1997 Mar; 4(1):64-7. PubMed ID: 9097368
    [No Abstract]   [Full Text] [Related]  

  • 19. Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient.
    Hofer A; Fleischhacker WW; Hummer M
    J Clin Psychiatry; 2003 Oct; 64(10):1267-8. PubMed ID: 14658980
    [No Abstract]   [Full Text] [Related]  

  • 20. Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behavioral functioning.
    Werz MA; Schoenberg MR; Meador KJ; Loring DW; Ray PG; Kaul-Gupta R; Ogrocki P
    Epilepsy Behav; 2006 Feb; 8(1):181-91. PubMed ID: 16377253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.